Not FDA-approved — and why that matters
Domperidone has never received FDA approval for any use in the United States. That is a different situation from many prescription medicines that are simply restricted to pharmacy dispensing; domperidone has no approved U.S. product at all, whether by prescription or otherwise. This single fact explains the vast majority of confusion people run into when searching for it: standard U.S. pharmacies cannot dispense it, and it is not something a typical primary care visit can result in a normal prescription for.
The regulatory history
Two separate threads explain how things ended up this way. First, the pharmaceutical company that developed domperidone did not pursue the full FDA approval process in the U.S. the way it did in Europe, Canada, and elsewhere. Second, and more consequentially, an intravenous (IV) formulation of domperidone given at high doses was linked to serious heart rhythm problems in FDA reviews conducted in the 1980s. That IV formulation was withdrawn, but the finding shaped the FDA's broader stance toward domperidone, including the oral tablet form that is approved and used safely, under monitoring, in many other countries today.
Where domperidone is approved
Oral domperidone is approved and available by prescription in more than 100 countries, including Canada, the United Kingdom, most of the European Union, Australia, and much of Latin America and Asia. In every one of these markets, it is dispensed as a prescription medicine, generally with the dose and duration limits described on our Side Effects & Safety page. There is no country where domperidone is sold as an over-the-counter product without a prescription.
What "getting domperidone in Canada or the UK" actually involves
Because domperidone is approved abroad, some people look into whether they can obtain it while traveling, through a contact overseas, or through an online pharmacy based in another country. A few realities are worth knowing before going down that path. Even where domperidone is legal, it still requires a local prescription from a licensed prescriber in that country — it is not an unrestricted purchase there either. Bringing a foreign prescription medicine into the United States for personal use sits in a legal gray area: the FDA has a narrow personal-importation policy that is applied case by case, mainly for serious conditions with no comparable FDA-approved option, and it is enforcement discretion rather than a guaranteed right. Products obtained this way are not verified by the FDA for authenticity, quality, or manufacturing standards, and shipments can be delayed or held at customs. None of this replaces an actual conversation with a physician about whether pursuing access makes sense for a specific medical situation.
The pathway for U.S. patients with a genuine medical need
For U.S. patients — most commonly those with chronic gastroparesis that has not responded to other approaches — the recognized legitimate route is the FDA's Expanded Access program, sometimes referred to as "compassionate use," accessed through an Investigational New Drug (IND) application. In practice, this means:
- A physician evaluates whether domperidone is appropriate given the patient's diagnosis, history, and other options tried
- The physician submits a request to the FDA under the Expanded Access framework, specific to that patient
- If authorized, a registered compounding pharmacy prepares the product under that authorization, with the physician monitoring the patient, including relevant cardiac screening
This is a physician-initiated, case-by-case medical process, not a retail or online purchase, and it can take time. Domperidone Motilium Guide does not initiate, facilitate, sell, or ship any part of this process; we describe it here purely so readers understand what the legitimate route looks like, in contrast to informal offers that skip medical oversight entirely.
A note on unverified online sources
Because domperidone cannot be obtained through a normal U.S. prescription, a number of websites offer to sell it directly, often without requiring any prescription or medical oversight. Products from unverified sources carry real risks: no confirmation of what is actually in the tablet, no dose accuracy guarantee, no cardiac risk screening, and no legal protection if something goes wrong. Given domperidone's specific, well-documented cardiac warning, skipping medical supervision is a materially different risk calculation than it would be for a lower-risk supplement. If cost or access is the barrier to the legitimate pathway above, that is worth raising directly with a physician, who may know of patient assistance programs or alternative options.
Bottom line: domperidone is not FDA-approved and is not legally available over the counter or through standard U.S. pharmacies. The only established legitimate route for U.S. patients is physician-led, through the FDA's Expanded Access program and a registered compounding pharmacy.
Related reading
For primary regulatory sources, see the U.S. FDA, Health Canada, and the UK MHRA.